TrialThe New England journal of medicine2000

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Heart Outcomes Prevention Evaluation Study Investigators et al.PubMed ↗Publisher ↗

No numbers read from the abstract.